• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在Aβ42/Aβ40混合物中,Aβ40对Aβ42原纤维形成有微妙影响,但程度低于Aβ42浓度。

Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.

作者信息

Terrill-Usery Shana E, Colvin Benjamin A, Davenport Richard E, Nichols Michael R

机构信息

Department of Chemistry and Biochemistry, Center for Nanoscience, University of Missouri, St. Louis, USA.

Department of Chemistry and Biochemistry, Center for Nanoscience, University of Missouri, St. Louis, USA.

出版信息

Arch Biochem Biophys. 2016 May 1;597:1-11. doi: 10.1016/j.abb.2016.03.017. Epub 2016 Mar 21.

DOI:10.1016/j.abb.2016.03.017
PMID:27013205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4841699/
Abstract

Recent findings suggest that the senile plaques in Alzheimer's disease may contain soluble amyloid-β peptide (Aβ) fibril precursors along with insoluble fibrils. These soluble Aβ species, including oligomers and protofibrils, have been well-studied in vitro and are formed via non-covalent self-assembly of Aβ monomers. While both 40- and 42-residue forms of Aβ are observed in the human body, the majority of the Aβ aggregation work has been conducted on Aβ42 or Aβ40 separately, with relatively few investigations of mixtures. In order to study the effect of different combinations of Aβ40 and Aβ42 on protofibril formation, mixtures of either dry solid peptide, or purified Aβ40 and Aβ42 monomer solutions were mixed together and protofibril/monomer distributions were quantified. Increases in the Aβ42/Aβ40 ratio increased protofibril formation but the presence of Aβ40 in the mixed Aβ solutions had a significant negative impact on protofibril formation compared to equivalent solutions of pure Aβ42. Protofibril size was less affected, but β-sheet structure increased with protofibrils formed from higher Aβ42/Aβ40 ratio solutions. Direct measurement of Aβ42/Aβ40 ratios by C-terminal-selective ELISA found very little Aβ40 incorporated into protofibrils. The cumulative data emphasizes the critical importance of Aβ42, yet establishes Aβ40 as a regulator of Aβ42 aggregation.

摘要

最近的研究结果表明,阿尔茨海默病中的老年斑可能含有可溶性淀粉样β肽(Aβ)纤维前体以及不溶性纤维。这些可溶性Aβ种类,包括寡聚体和原纤维,已在体外得到充分研究,它们是通过Aβ单体的非共价自组装形成的。虽然在人体中观察到了40个和42个残基形式的Aβ,但大多数Aβ聚集研究都是分别针对Aβ42或Aβ40进行的,对混合物的研究相对较少。为了研究Aβ40和Aβ42的不同组合对原纤维形成的影响,将干燥的固体肽混合物或纯化的Aβ40和Aβ42单体溶液混合在一起,并对原纤维/单体分布进行定量。Aβ42/Aβ40比值的增加会增加原纤维的形成,但与纯Aβ42的等效溶液相比,混合Aβ溶液中Aβ40的存在对原纤维形成有显著的负面影响。原纤维大小受影响较小,但由较高Aβ42/Aβ40比值溶液形成的原纤维的β-折叠结构增加。通过C端选择性ELISA直接测量Aβ42/Aβ40比值发现,很少有Aβ40掺入原纤维中。累积数据强调了Aβ42的至关重要性,但也确定Aβ40是Aβ42聚集的调节剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/07675ffe75bb/nihms772745f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/348745b3bb2b/nihms772745f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/3ef192064ae7/nihms772745f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/2930b23d4b8a/nihms772745f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/a26c75eb7e9d/nihms772745f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/579f58c12ec7/nihms772745f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/ae577d872a35/nihms772745f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/3915cb73cf3b/nihms772745f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/d4d53d7d97d5/nihms772745f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/07675ffe75bb/nihms772745f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/348745b3bb2b/nihms772745f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/3ef192064ae7/nihms772745f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/2930b23d4b8a/nihms772745f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/a26c75eb7e9d/nihms772745f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/579f58c12ec7/nihms772745f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/ae577d872a35/nihms772745f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/3915cb73cf3b/nihms772745f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/d4d53d7d97d5/nihms772745f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df8b/4841699/07675ffe75bb/nihms772745f9.jpg

相似文献

1
Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.在Aβ42/Aβ40混合物中,Aβ40对Aβ42原纤维形成有微妙影响,但程度低于Aβ42浓度。
Arch Biochem Biophys. 2016 May 1;597:1-11. doi: 10.1016/j.abb.2016.03.017. Epub 2016 Mar 21.
2
Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains.Lecanemab 能高度选择性地结合从阿尔茨海默病患者脑中分离得到的 Aβ原纤维。
Mol Cell Neurosci. 2024 Sep;130:103949. doi: 10.1016/j.mcn.2024.103949. Epub 2024 Jun 20.
3
Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.通过 D-对映体十肽 rk10 缓解 Aβ 聚集和原纤维解稳的机制见解。
Phys Chem Chem Phys. 2022 Sep 21;24(36):21975-21994. doi: 10.1039/d2cp02601e.
4
The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.一种新型Aβ42原纤维选择性抗体的构象表位与肽N端区域部分重叠。
J Neurochem. 2017 Dec;143(6):736-749. doi: 10.1111/jnc.14211. Epub 2017 Nov 22.
5
Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.阿尔茨海默病 Aβ42 和 Aβ40 肽形成交错的淀粉样纤维。
J Neurochem. 2013 Aug;126(3):305-11. doi: 10.1111/jnc.12202. Epub 2013 Mar 12.
6
The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.淀粉样前体蛋白40(Abeta40)和淀粉样前体蛋白42(Abeta42)的单体形式与聚集形式的比例是β淀粉样蛋白聚集、纤维形成和毒性的重要决定因素。
J Biol Chem. 2008 Oct 17;283(42):28176-89. doi: 10.1074/jbc.M803159200. Epub 2008 Aug 11.
7
A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.基于电子顺磁共振数据和罗塞塔建模的阿尔茨海默病Aβ42原纤维新结构模型
J Struct Biol. 2016 Apr;194(1):61-7. doi: 10.1016/j.jsb.2016.01.013. Epub 2016 Jan 28.
8
Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.二氢查尔酮分子通过与原纤维腔结合来破坏阿尔茨海默病淀粉样-β原纤维。
Phys Chem Chem Phys. 2018 Jun 27;20(25):17208-17217. doi: 10.1039/c8cp01631c.
9
A new class of monoclonal Aβ antibodies selectively targets and triggers deposition of Aβ protofibrils.一类新型的单克隆 Aβ 抗体能选择性地靶向并引发 Aβ 原纤维的沉积。
J Neurochem. 2023 Jun;165(6):860-873. doi: 10.1111/jnc.15817. Epub 2023 Apr 19.
10
The C-terminal threonine of Aβ43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils.Aβ43 羧基端的苏氨酸通过单体和原纤维结构和动力学的变化引发毒性聚集。
Biochemistry. 2014 May 20;53(19):3095-105. doi: 10.1021/bi500131a. Epub 2014 May 7.

引用本文的文献

1
Evidence supportive of a bacterial component in the etiology for Alzheimer's disease and for a temporal-spatial development of a pathogenic microbiome in the brain.支持阿尔茨海默病病因中有细菌成分的证据,以及大脑中病原微生物组在时间和空间上发展的证据。
Front Cell Infect Microbiol. 2023 Sep 13;13:1123228. doi: 10.3389/fcimb.2023.1123228. eCollection 2023.
2
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease.用于阿尔茨海默病中淀粉样蛋白聚集建模的基于生理的药代动力学和定量系统药理学综合模型。
CPT Pharmacometrics Syst Pharmacol. 2023 Apr;12(4):444-461. doi: 10.1002/psp4.12912. Epub 2023 Jan 20.
3

本文引用的文献

1
2015 Alzheimer's disease facts and figures.2015 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2015 Mar;11(3):332-84. doi: 10.1016/j.jalz.2015.02.003.
2
Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.可溶性淀粉样β蛋白(1-42)原纤维、寡聚体和原丝的生物物理比较
Biochemistry. 2015 Apr 7;54(13):2193-204. doi: 10.1021/bi500957g. Epub 2015 Mar 24.
3
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease.
Looking at Alzheimer's Disease Pathogenesis from the Nuclear Side.
从核方面看阿尔茨海默病的发病机制。
Biomolecules. 2021 Aug 24;11(9):1261. doi: 10.3390/biom11091261.
4
Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer's disease neurons.肿瘤坏死因子可诱导人类阿尔茨海默病神经元产生更多含细胞外淀粉样β蛋白和α-突触核蛋白的聚集体。
Brain Commun. 2020 Sep 15;2(2):fcaa146. doi: 10.1093/braincomms/fcaa146. eCollection 2020.
5
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.阿尔茨海默病脑源性可溶性 Aβ 寡聚体损伤突触可塑性的机制假说。
J Neurochem. 2020 Sep;154(6):583-597. doi: 10.1111/jnc.15007. Epub 2020 Apr 5.
6
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.在阿尔茨海默病进展过程中,脑脊液中存在的可溶性聚集物在大小和毒性机制上发生变化。
Acta Neuropathol Commun. 2019 Jul 26;7(1):120. doi: 10.1186/s40478-019-0777-4.
7
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms.不同可溶性 Aβ42 聚集体通过不同的机制引发细胞毒性。
Nat Commun. 2019 Apr 4;10(1):1541. doi: 10.1038/s41467-019-09477-3.
8
UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ.基于 UHPLC-QTOF/MS 的代谢组学研究丹参在 Aβ诱导的阿尔茨海默病细胞模型中的保护机制。
Metabolomics. 2019 Jan 17;15(2):13. doi: 10.1007/s11306-019-1473-x.
9
The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.一种新型Aβ42原纤维选择性抗体的构象表位与肽N端区域部分重叠。
J Neurochem. 2017 Dec;143(6):736-749. doi: 10.1111/jnc.14211. Epub 2017 Nov 22.
未来阿尔茨海默病疗法的展望:淀粉样蛋白-β原纤维——阿尔茨海默病 BAN2401 免疫疗法的新靶点。
Alzheimers Res Ther. 2014 Mar 24;6(2):16. doi: 10.1186/alzrt246. eCollection 2014.
4
The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.通过独特的途径,等量的阿尔茨海默病淀粉样β 40 和 42 形成结构稳定且有毒的寡聚物。
FEBS J. 2014 Jun;281(11):2674-87. doi: 10.1111/febs.12813. Epub 2014 May 6.
5
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.阿尔茨海默病:流行病学、诊断标准、危险因素和生物标志物。
Biochem Pharmacol. 2014 Apr 15;88(4):640-51. doi: 10.1016/j.bcp.2013.12.024. Epub 2014 Jan 4.
6
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker.血浆淀粉样蛋白β测量 - 阿尔茨海默病的理想但难以捉摸的生物标志物。
Alzheimers Res Ther. 2013 Mar 8;5(2):8. doi: 10.1186/alzrt162. eCollection 2013.
7
Amyloid-β(1-42) protofibrils formed in modified artificial cerebrospinal fluid bind and activate microglia.改性人工脑脊液中形成的淀粉样蛋白-β(1-42)原纤维结合并激活小胶质细胞。
J Neuroimmune Pharmacol. 2013 Mar;8(1):312-22. doi: 10.1007/s11481-012-9424-6. Epub 2012 Dec 16.
8
The genetics of Alzheimer disease.阿尔茨海默病的遗传学。
Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a006296. doi: 10.1101/cshperspect.a006296.
9
Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia.单体淀粉样β(1-42)原纤维,而非单体纤维,可强有力地刺激小神经胶质细胞。
ACS Chem Neurosci. 2012 Apr 18;3(4):302-11. doi: 10.1021/cn2001238. Epub 2012 Jan 9.
10
Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.阿尔茨海默病中β淀粉样蛋白和淀粉样沉积物的生物化学。
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006262. doi: 10.1101/cshperspect.a006262.